perrigo co
Perrigo Launches First-Ever Industry Marketing Campaign For Store Brand OTC Medications
Perrigo Co. announced it has kicked off a broad industry marketing and communications campaign to raise awareness for, and consumer confidence in, generic over-the-counter medications sold at leading retailers — also known as “store brand” OTCs.
Perrigo Reports Record Revenue; Acquisition Charges Ding Profits
The generic drug and store brand health products maker Perrigo Co. (Nasdaq: PRGO) Wednesday reported record revenue of $919.8 million in the third fiscal quarer ended March 30, up from $778 million a year earlier.
Perrigo Starting Shipments of Guaifenesin Extended-Release 600mg
Perrigo Co. (Nasdaq: PRGO) Monday announced that it has begun shipments of Guaifenesin 600mg Extended-Release tablets in a launch to its retail and wholesale customers
Perrigo Announces Quarterly Dividend
Perrigo Co. (Nasdaq: PRGO) Thursday announced that its board of directors declared a quarterly dividend of 9 cents a share.
14 Companies To Add 4,590 Michigan Jobs, Invest $1.1 Billion
The Michigan Strategic Fund Wednesday approved state incentives to support 14 business expansions that are expected to generate more than $1.1 billion in investments and add 4,590 jobs in Michigan.
Perrigo Launches Store Brand Version Of Nicorette Mini Nicotine Lozenges
The Perrigo Company (Nasdaq: PRGO) announced that it has begun shipments of over-the-counter nicotine polacrilex mini lozenge USP, 2 mg (mint flavor) and 4 mg (mint flavor).
Perrigo Announces Commercial Launch Of Betamethasone Foam
Perrigo Co. Tuesday announced that it has begun commercial shipments of betamethasone valerate foam 0.12%, the generic equivalent of Luxiq Foam, consistent with the date certain launch settlement previously announced.
Perrigo Announces Launch of Authorized Generic Version of Acetadote, Plus Infant Formulas
Allegan-based Perrigo Co. announced that it has made initial shipments distributing Cumberland Pharmaceuticals Inc.’s authorized generic form of Acetadote (acetylcysteine) injection, and that it had received FDA clearance to manufacture new infant formula products.
HR Notices From December 4
The latest staffing, leadership and boardroom news from Michigan’s technology-focused companies, institutions and groups
Perrigo Confirms Settlement Of Generic Acetadote Injection Patent Lawsuit
The generic drug and over-the-counter health product manufacturer Perrigo Co. (Nasdaq: PRGO) announced that it has agreed to settle its Hatch-Waxman litigation relating to Acetadote (acetylcysteine) injection brought by Cumberland Pharmaceuticals Inc.
Latest Galleries
CBS Detroit Blogs
- Car Chronicles Blog – Cars, Kids and Common Sense May 18, 2013
- The Reunion Project – Friday Fun (5/17) May 17, 2013
- Trey Burke Talks Fab Five, Detroit Pistons With Ryan Wooley May 13, 2013
- Leach’s Lists: Three Keys For The Red Wings To Win Game 7 May 11, 2013
